Stay on top of what’s happening in the Bay Area with essential Bay Area news stories, sent to your inbox every weekday.

Bay Area-raised host Ericka Cruz Guevarra brings you context and analysis to make sense of the news. Episodes drop Monday, Wednesday, and Friday.

See TV Programming Manager Emma Casley’s recommendations from this month’s KQED 9, PLUS and Passport schedules.

Support KQED by using your donor-advised fund to make a charitable gift.

Stay on top of what’s happening in the Bay Area with essential Bay Area news stories, sent to your inbox every weekday.

Bay Area-raised host Ericka Cruz Guevarra brings you context and analysis to make sense of the news. Episodes drop Monday, Wednesday, and Friday.

See TV Programming Manager Emma Casley’s recommendations from this month’s KQED 9, PLUS and Passport schedules.

Support KQED by using your donor-advised fund to make a charitable gift.

A Bay Area lawmaker slammed a Trump administration plan to conduct research on the Hepatitis B vaccine on infants in Guinea-Bissau, where nearly one in five adults lives with the virus.
The grant, awarded to a group of Danish scientists with ties to the anti-vaccine movement, will fund a five-year randomized control trial in the West African nation. According to the House Science, Space, and Technology Committee, 14,000 newborns will either receive the vaccine at birth or after a six-week delay to compare health outcomes.
South Bay Rep. Zoe Lofgren (D-San José) called the decision to approve the $1.6 million dollar study — which followed the Centers for Disease Control and Prevention rollback of newborn Hepatitis B vaccine recommendations last week — “deplorable” and a “new low.”

A Bay Area lawmaker slammed a Trump administration plan to conduct research on the Hepatitis B vaccine on infants in Guinea-Bissau, where nearly one in five adults lives with the virus.